4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Gelteq Limited (GELS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Clayton, Australia with about 7 employees. Its market capitalization is roughly $6 million. In the fiscal year ended 2025-06-30, GELS reported $0M in revenue and ($7M) in net income.
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.
Interactive charts & full statements → Open the GELS valuation workbench →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Gross Profit | — | $0M | $0M | $0M |
| Operating Income (EBIT) | ($5M) | ($3M) | ($3M) | ($3M) |
| Net Income | ($7M) | ($4M) | ($4M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | $22M | $21M | $22M | $23M |
| Total Liabilities | $6M | $6M | $4M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GELS viewer.
About TickerBase · Data methodology & sources